Editor's Recommendations
Most Read Articles
09 Dec 2016
All patients with acne are potentially at risk of scarring. Professor Goh Chee Leok addresses this issue by focussing on preventing the development of scars in his talk at the 41st Annual Meeting of the Dermatological Society of Malaysia held in Kuching, Sarawak.
05 Jan 2017
Olumacostat glasaretil (OG) appears to be effective and is well tolerated in patients with moderate to severe facial acne vulgaris, suggesting the need for further development, according to a new study.
Tristan Manalac, 10 Mar 2018
Cost of treatment is a major driver of patients’ primary nonadherence to acne medication, according to a recent study. Physicians who openly discuss medications costs and provide a plan of action in case patients are unable to fill prescriptions may improve treatment adherence.
Stephen Padilla, 10 Nov 2016
New topical formulation BiRetix gel Ultra (BR gel) is effective and well tolerated in individuals with mild to moderate acne, reducing both noninflammatory (NI-L) and inflammatory acne lesions (IL), a recent study has found. In addition, BR gel has good skin tolerability and can be considered as first-line treatment for predominant comedonal.